Iliac Stent Market Projected to Surge with Key Drivers Including Aging Population, Healthcare Advancements, and Rising Prevalence of PAD

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Iliac Stent Market- (Type (Self-expandable Stents, Balloon-expandable Stents and Others), By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesion and Complete Obstructive Lesions), By End-use (Hospitals, Outpatient Facilities and Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Iliac Stent Market is valued at US$ 1.02 Bn in 2023, and it is expected to reach US$ 1.61 Bn by 2031, with a CAGR of 6.07% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2416

An iliac stent is a small, steel-mesh device designed for insertion into the iliac artery, a major blood vessel in the pelvis responsible for supplying blood to the lower extremities. In patients with cardiovascular conditions, such as atherosclerosis, the primary goal of iliac stent placement is to relieve arterial narrowing or blockage, thereby restoring adequate blood flow.

The growing demand for iliac stents is driven by several factors, including increased awareness of minimally invasive procedures, the rising prevalence of peripheral artery disease (PAD), and continuous advancements in medical technology. Innovations in stent design and materials have led to improved patient outcomes, further contributing to market growth. Additionally, heightened awareness among both patients and healthcare providers about the advantages of iliac stenting compared to alternative treatment options is facilitating its broader adoption.

However, the market faces challenges such as stringent regulatory requirements and the availability of alternative therapies for cardiovascular conditions, which may pose barriers to growth. Despite these challenges, the market is expected to expand due to factors such as an aging population susceptible to peripheral vascular diseases, increased healthcare investments, a growing pool of skilled medical professionals, pharmaceutical companies pursuing market opportunities, and greater patient awareness of advanced treatment options.

List of Prominent Players in the Iliac Stent Market:
• BD
• Abbott
• Boston Scientific Corporation
• W. L. Gore & Associates, Inc.
• Medtronic
• Cook
• Terumo Corporation
• iVascular
• Getinge AB
• Biotronik SE & Co KG

Market Dynamics:
Drivers-
The global stent industry plays a crucial role in driving the expansion of the iliac stent market, underpinned by several key factors, including the increasing demand for minimally invasive surgical procedures, advancements in medical device technology, and the growing prevalence of cardiovascular diseases globally. These factors collectively serve as significant drivers for market growth.

Moreover, self-expandable stents hold a considerable market share due to their demonstrated effectiveness in treating conditions affecting the external iliac artery. Additionally, strategic initiatives by leading market participants, such as the development of new products, regulatory approvals, and enhanced awareness of peripheral artery diseases, are further contributing to the accelerated growth of the market.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Challenges:
The iliac stent market faces several challenges that could impede its growth, including the availability of alternative treatment options, stringent regulatory requirements, and the complexities associated with angioplasty procedures. The presence of alternative cardiovascular treatments poses a significant barrier, potentially deterring both patients and healthcare providers from opting for stent implantation. Additionally, product recalls and complications during stenting procedures may further hinder market expansion. Another key challenge lies in the regulatory approval process, as stringent compliance requirements can delay the introduction of innovative stent technologies, thereby slowing market growth.

Regional Trends:
North America is anticipated to maintain a dominant position in the iliac stent market in terms of revenue share, with projections indicating a robust compound annual growth rate (CAGR) in the coming years. This growth is driven by the increasing prevalence of disease, rising public awareness, strong government initiatives, rapid advancements in medical technology, and ongoing improvements in healthcare infrastructure. Additionally, the presence of leading iliac stent manufacturers in the region, along with an aging population and a growing incidence of peripheral artery disease, continues to fuel market demand, particularly in the United States.

Similarly, Europe holds a significant share of the market, supported by an increase in vascular procedures, technological advancements in medical devices, and government-led healthcare initiatives. The growing adoption of endovascular procedures also serves as a key driver of market expansion in the region.

Recent Developments:
• In January 2024, Abbott announced the launch of NavitorTM, their next-generation transcatheter aortic valve implantation (TAVI) system. This minimally invasive technology will now be accessible to patients in India who suffer from severe aortic stenosis and are deemed to be at high or extreme risk for surgery. The Navitor TAVI system is the newest offering from the company's extensive structural heart transcatheter portfolio, providing patients and doctors with less invasive alternatives for treating heart disorders.
• In February 2024, BD and the world's foremost manufacturer of laboratory automation technology, Hamilton, announced a partnership to create robotics-compatible reagent kits and automated applications that allow larger-scale single-cell multi-omics experiments to be conducted with more precision and less room for human error.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2416

Segmentation of Iliac Stent Market-
Iliac Stent Market-By Type
• Self-expandable Stents
• Balloon-expandable Stents
• Others
Iliac Stent Market-By Artery Lesions
• Common Iliac Artery Lesions
• Severe Calcified Lesions
• Complete Obstructive Lesions
Iliac Stent Market-By End-Use
• Hospitals
• Outpatient Facilities
• Others
Iliac Stent Market-By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

View Overview Report: https://www.insightaceanalytic.com/report/iliac-stents-market/2416

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.